Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 2313850, 9 pages
http://dx.doi.org/10.1155/2016/2313850
Research Article

Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma

1Department of Pathology and Laboratory Medicine, Rutgers, The State University of New Jersey, Newark, NJ 07103, USA
2Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA

Received 21 July 2016; Revised 24 September 2016; Accepted 26 September 2016

Academic Editor: Andrea C. Gardini

Copyright © 2016 Qunfeng Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Roskams, N. D. Theise, C. Balabaud et al., “Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers,” Hepatology, vol. 39, no. 6, pp. 1739–1745, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. H. Gouw, A. D. Clouston, and N. D. Theise, “Ductular reactions in human liver: diversity at the interface,” Hepatology, vol. 54, no. 5, pp. 1853–1863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Williams, A. D. Clouston, and S. J. Forbes, “Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion,” Gastroenterology, vol. 146, no. 2, pp. 349–356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Okabe, Y. Tsukahara, M. Tanaka et al., “Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver,” Development, vol. 136, no. 11, pp. 1951–1960, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Lanzoni, V. Cardinale, and G. Carpino, “The hepatic, biliary, and pancreatic network of stem/progenitor cell niches in humans: a new reference frame for disease and regeneration,” Hepatology, vol. 64, no. 1, pp. 277–286, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. K. N. Lowes, B. A. Brennan, G. C. Yeoh, and J. K. Olynyk, “Oval cell numbers in human chronic liver diseases are directly related to disease severity,” The American Journal of Pathology, vol. 154, no. 2, pp. 537–541, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. D. Clouston, E. E. Powell, M. J. Walsh, M. M. Richardson, A. J. Demetris, and J. R. Jonsson, “Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis,” Hepatology, vol. 41, no. 4, pp. 809–818, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Roskams, S. Q. Yang, A. Koteish et al., “Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease,” American Journal of Pathology, vol. 163, no. 4, pp. 1301–1311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. Richardson, J. R. Jonsson, E. E. Powell et al., “Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction,” Gastroenterology, vol. 133, no. 1, pp. 80–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Y. Xiao, L. Lu, and H. L. Wang, “Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis,” International Journal of Clinical and Experimental Pathology, vol. 1, no. 1, pp. 396–402, 2008. View at Google Scholar
  11. M. J. Wood, V. L. Gadd, L. W. Powell, G. A. Ramm, and A. D. Clouston, “Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression,” Hepatology, vol. 59, no. 3, pp. 848–857, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Sell, “The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma,” The International Journal of Developmental Biology, vol. 37, no. 1, pp. 189–201, 1993. View at Google Scholar · View at Scopus
  13. M. Komuta, B. Spee, S. Vander Borght et al., “Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin,” Hepatology, vol. 47, no. 5, pp. 1544–1556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. L. Dumble, E. J. Croager, G. C. T. Yeoh, and E. A. Quail, “Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma,” Carcinogenesis, vol. 23, no. 3, pp. 435–445, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. N. D. Theise, J. L. Yao, K. Harada et al., “Hepatic ‘stem cell’ malignancies in adults: four cases,” Histopathology, vol. 43, no. 3, pp. 263–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Cardinale, R. Semeraro, A. Torrice et al., “Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors,” World Journal of Gastrointestinal Oncology, vol. 2, no. 11, pp. 407–416, 2010. View at Publisher · View at Google Scholar
  17. O. Govaere, M. Komuta, J. Berkers et al., “Keratin 19: a key role player in the invasion of human hepatocellular carcinomas,” Gut, vol. 63, no. 4, pp. 674–685, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Komuta, O. Govaere, V. Vandecaveye et al., “Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes,” Hepatology, vol. 55, no. 6, pp. 1876–1888, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. The International Agency for Research on Cancer, “WHO classification of tumours of the digestive system,” in IARC WHO Classification of Tumours, F. T. Bosman, F. Carneiro, R. H. Hruban, and N. D. Theise, Eds., pp. 1–418, World Health Organization, Geneva, Switzerland, 4th edition, 2010. View at Google Scholar
  20. F. Zhang, X.-P. Chen, W. Zhang et al., “Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: Immunohistochemical and double-fluorescence immunostaining evidence,” Histopathology, vol. 52, no. 2, pp. 224–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G.-W. Zuo, C. D. Kohls, B.-C. He et al., “The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis,” Histology and Histopathology, vol. 25, no. 6, pp. 795–806, 2010. View at Google Scholar · View at Scopus
  22. B. Spee, G. Carpino, B. A. Schotanus et al., “Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling,” Gut, vol. 59, no. 2, pp. 247–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Weiskirchen, “CCN proteins in normal and injured liver,” Frontiers in Bioscience, vol. 16, no. 5, pp. 1939–1961, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Jia, Q. Dong, and L. Qin, “CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?” Oncotarget, vol. 7, no. 2, pp. 1203–1214, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zhang, W. Li, P. Huang et al., “Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma,” Oncology Reports, vol. 33, no. 3, pp. 1481–1492, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Fickert, U. Stöger, A. Fuchsbichler et al., “A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis,” The American Journal of Pathology, vol. 171, no. 2, pp. 525–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Pi, P. M. Robinson, M. Jorgensen et al., “Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice,” Hepatology, vol. 61, no. 2, pp. 678–691, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Tanaka, K. Sugimachi, T. Kameyama et al., “Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma,” Hepatology, vol. 37, no. 5, pp. 1122–1129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Wang, M. Foster, M. Al-Dhalimy, E. Lagasse, M. Finegold, and M. Grompe, “The origin and liver repopulating capacity of murine oval cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 1, pp. 11881–11888, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Gardini, B. Corti, M. Fiorentino et al., “Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma,” Digestive and Liver Disease, vol. 37, no. 4, pp. 269–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Gaunitz, D. Deichsel, K. Heise, M. Werth, U. Anderegg, and R. Gebhardt, “An intronic silencer element is responsible for specific zonal expression of glutamine synthetase in the rat liver,” Hepatology, vol. 41, no. 6, pp. 1225–1232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. O. A. Gressner and A. M. Gressner, “Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases,” Liver International, vol. 28, no. 8, pp. 1065–1079, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Huang and D. R. Brigstock, “Regulation of hepatic stellate cells by connective tissue growth factor,” Frontiers in Bioscience, vol. 17, pp. 2495–2507, 2012. View at Publisher · View at Google Scholar
  34. Z. Tong, R. Chen, D. S. Alt, S. Kemper, B. Perbal, and D. R. Brigstock, “Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes,” Hepatology, vol. 50, no. 3, pp. 939–947, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. Y.-C. Jian, J.-J. Wang, S. Dong et al., “Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo,” Clinical Laboratory, vol. 60, no. 1, pp. 29–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Li, Y. Chen, W. Ye et al., “Blockade of CCN4 attenuates CCl4-induced liver fibrosis,” Archives of Medical Science, vol. 11, no. 3, pp. 647–653, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. K.-H. Kim, C.-C. Chen, R. I. Monzon, and L. F. Lau, “Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts,” Molecular and Cellular Biology, vol. 33, no. 10, pp. 2078–2090, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Abd El Kader, S. Kubota, D. Janune et al., “Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family,” Journal of Cell Communication and Signaling, vol. 7, no. 1, pp. 11–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Borkham-Kamphorst, B. T. Steffen, E. Van de Leur et al., “CCN1/CYR61 overexpression in hepatic stellate cells induces ER stress-related apoptosis,” Cellular Signalling, vol. 28, no. 1, pp. 34–42, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Borkham-Kamphorst, C. R. van Roeyen, E. Van de, J. Lear, and R. Weiskirchen, “CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC,” Journal of Cell Communication and Signaling, vol. 6, no. 1, pp. 11–25, 2012. View at Publisher · View at Google Scholar
  41. K.-H. Kim, C.-C. Chen, G. Alpini, and L. F. Lau, “CCN1 induces hepatic ductular reaction through integrin αvβ5-mediated activation of NF-κB,” Journal of Clinical Investigation, vol. 125, no. 5, pp. 1886–1900, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Pi, S.-H. Oh, T. Shupe, and B. E. Petersen, “Role of connective tissue growth factor in oval cell response during liver regeneration after 2-AAF/PHx in rats,” Gastroenterology, vol. 128, no. 7, pp. 2077–2088, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Pi, X. Ding, M. Jorgensen et al., “Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation,” Hepatology, vol. 47, no. 3, pp. 996–1004, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. C. C. Chen, K. H. Kim, and L. F. Lau, “The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation,” Oncogene, vol. 35, no. 10, pp. 1314–1323, 2016. View at Publisher · View at Google Scholar
  45. Z.-Q. Li, W. Ding, S.-J. Sun et al., “Cyr61/CCN1 is regulated by wnt/β-catenin signaling and plays an important role in the progression of hepatocellular carcinoma,” PLoS ONE, vol. 7, no. 4, Article ID e35754, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Xiu, Y.-H. Liu, D. R. Brigstock, F.-H. He, R.-J. Zhang, and R.-P. Gao, “Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth,” World Journal of Gastroenterology, vol. 18, no. 47, pp. 7070–7078, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Hirasaki, N. Koide, K. Ujike, T. Shinji, and T. Tsuji, “Expression of Nov, CYR61 and CTGF genes in human hepatocellular carcinoma,” Hepatology Research, vol. 19, no. 3, pp. 294–305, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. F.-E. Mo, A. G. Muntean, C.-C. Chen, D. B. Stolz, S. C. Watkins, and L. F. Lau, “CYR61 (CCN1) is essential for placental development and vascular integrity,” Molecular and Cellular Biology, vol. 22, no. 24, pp. 8709–8720, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Ivkovic, B. S. Yoon, S. N. Popoff et al., “Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development,” Development, vol. 130, no. 12, pp. 2779–2791, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Shimoyama, S. Hiraoka, M. Takemoto et al., “CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 675–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Maeda, M. Ono, K. Holmbeck et al., “WNT1-induced Secreted Protein-1 (WISP1), a novel regulator of bone turnover and Wnt signaling,” The Journal of Biological Chemistry, vol. 290, no. 22, pp. 14004–14018, 2015. View at Publisher · View at Google Scholar
  52. S. Hann, L. Kvenvold, B. N. Newby, M. Hong, and M. L. Warman, “A Wisp3 Cre-knockin allele produces efficient recombination in spermatocytes during early prophase of meiosis I,” PLoS ONE, vol. 8, no. 9, Article ID e75116, 2013. View at Publisher · View at Google Scholar · View at Scopus